Author:
Zhang Hua,Gao Liuwei,Zhang Bin,Zhang Lianmin,wang Changli
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. International Agency for Research on Cancer, W.H.O GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. (2012)Available at:
http://globocaniarcfr
. (Accessed:12th January 2014).
2. Koh, C. H. et al. Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer 113, 150–158 (2015).
3. Raungkaewmanee, S., Tangjitgamol, S., Manusirivithaya, S., Srijaipracharoen, S. & Thavaramara, T. Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol 23, 265–273 (2012).
4. Smith, R. A. et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg 197, 466–472 (2009).
5. Kwon, H. C. et al. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 17, 216–222 (2012).
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献